Does high sensitive CRP improve cardiovascular risk prediction in metabolic syndrome among the aged?

Marika Salminen1, Marikka Kuoppamäki, Tero Vahlberg

  • 1Institute of Clinical Medicine, Family Medicine, FI-20014 University of Turku, Turku, Finland. majosa@utu.fi

Insights

High-sensitivity C-reactive protein (hsCRP) does not add value in predicting cardiovascular events or mortality in older adults with metabolic syndrome (MetS). This study found no significant interaction between hsCRP levels and MetS for these outcomes.

Area of Science:

  • Gerontology
  • Cardiology
  • Biomarkers

Background:

  • Metabolic syndrome (MetS) is a cluster of conditions increasing cardiovascular disease (CVD) risk.
  • High-sensitivity C-reactive protein (hsCRP) is an inflammatory marker associated with CVD.
  • The additive prognostic value of hsCRP in older adults with MetS requires further investigation.

Purpose of the Study:

  • To determine if elevated hsCRP levels provide additional predictive value for cardiovascular events (CVEs) and all-cause mortality in elderly individuals with MetS.
  • To analyze the interaction between hsCRP and MetS in predicting future cardiovascular events and mortality in the aged population.

Main Methods:

  • A prospective, population-based study followed 733 individuals aged 64+ for 9 years.
  • Participants were free of vascular disease and had CRP < 10 mg/l at baseline.
  • Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated for CVEs and all-cause mortality, considering MetS (IDF and WHO definitions) and hsCRP levels.

Main Results:

  • Over 9 years, 142 CVEs and 206 deaths occurred.
  • No significant interaction was found between hsCRP and MetS for CVEs or all-cause mortality (p > 0.05 for all interaction tests).
  • hsCRP alone was not significantly associated with CVEs or all-cause mortality in this cohort.

Conclusions:

  • Elevated hsCRP does not appear to offer additional predictive value for cardiovascular events or all-cause mortality in older subjects already diagnosed with metabolic syndrome.
  • Current inflammatory markers like hsCRP may not enhance risk stratification beyond MetS criteria in the elderly.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...